Inactivation of dihydropyrimidine dehydrogenase by 5-iodouracil.

作者: D.J. Porter , W.G. Chestnut , L.C. Taylor , B.M. Merrill , T. Spector

DOI: 10.1016/S0021-9258(18)54881-X

关键词:

摘要: 5-Iodouracil was a substrate for bovine liver dihydropyrimidine dehydrogenase (DHPDHase) and potent inactivator of the enzyme. NADPH increased rate inactivation thymine protected against inactivation. These findings suggest that 5-iodouracil mechanism-based inactivator. However, dithiothreitol excess enzyme Thus, reactive product, presumably 5-iodo-5,6-dihydrouracil generated through enzymatic reduction 5-iodouracil, released from DHPDHase during processing 5-iodouracil. Since only 18% [6-3H]5-iodouracil reduced by covalently bound to radiolabel not lost solvent as tritium, partition coefficient 4.5. activity completely titrated with 1.7 mol per enzyme-bound flavin. results indicate there 0.31 This suggests were 3.2 flavins active site, which is consistent report multiple enzymic subunit (Podschun, B., Wahler, G., Schnackerz, K. D. (1989) Eur. J. Biochem. 185, 219-224). inactivated 2.1 racemic sites. The stoichiometry nonenzymatically enantiomer calculated be 1. Two radiolabeled fragments isolated tryptic digest amino acid sequences these peptides Asn-Leu-Ser-X-Pro-His Asn-Leu-Ser-X-Pro-His-Gly-Met-Gly-Glu-Arg where X modified containing [6-3H]5-iodouracil. Fast atom bombardment mass spectral analysis smaller peptide yielded protonated parent ion 782 daltons being S-(hexahydro-2,4-dioxo-5-pyrimidinyl)cysteinyl residue.

参考文章(20)
T. Shiotani, G. Weber, Purification and properties of dihydrothymine dehydrogenase from rat liver. Journal of Biological Chemistry. ,vol. 256, pp. 219- 224 ,(1981) , 10.1016/S0021-9258(19)70122-7
I K Dev, B B Yates, J Atashi, W S Dallas, Catalytic role of histidine 147 in Escherichia coli thymidylate synthase Journal of Biological Chemistry. ,vol. 264, pp. 19132- 19137 ,(1989) , 10.1016/S0021-9258(19)47277-3
Iigo Masaaki, Nishikata Ken-Ichi, Nakajima Yoko, Hoshi akio, Okudaira Noriko, Odagiri Hisashi, Erik De Clercq, Enhancing effect of bromovinyldeoxyuridine on antitumor activity of 5′-deoxy-5-fluorouridine against adenocarcinoma 755 in mice: Correlation with pharmacokinetics of plasma 5-fluorouracil levels Biochemical Pharmacology. ,vol. 38, pp. 1885- 1889 ,(1989) , 10.1016/0006-2952(89)90485-1
Geoffrey M. Cooper, Geoffrey M. Cooper, Sheldon Greer, Irreversible inhibition of dehalogenation of 5-iodouracil by 5-diazouracil and reversible inhibition by 5-cyanouracil. Cancer Research. ,vol. 30, pp. 2937- 2941 ,(1970)
Raymond W Klecker, Jean F Jenkins, Timothy J Kinsella, Robert L Fine, John M Strong, Jerry M Collins, Clinical pharmacology of 5-iodo-2′-deoxyuridine and 5-iodouracil and endogenous pyrimidine modulation Clinical Pharmacology and Therapeutics. ,vol. 38, pp. 45- 51 ,(1985) , 10.1038/CLPT.1985.132
Sandro Ghisla, Vincent Massey, Jean-Marc Lhoste, Stephen G. Mayhew, Fluorescence and optical characteristics of reduced flavines and flavoproteins. Biochemistry. ,vol. 13, pp. 589- 597 ,(1974) , 10.1021/BI00700A029
Fardos N.M. Naguib, Mahmoud H. El Kouni, Sungman Cha, Structure-activity relationship of ligands of dihydrouracil dehydrogenase from mouse liver. Biochemical Pharmacology. ,vol. 38, pp. 1471- 1480 ,(1989) , 10.1016/0006-2952(89)90187-1
Yusuke Wataya, Daniel V. Santi, Thymidylate synthetase catalyzed dehalogenation of 5-bromo-and 5-iodo-2′-deoxyuridylate Biochemical and Biophysical Research Communications. ,vol. 67, pp. 818- 823 ,(1975) , 10.1016/0006-291X(75)90886-4